We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.2B
1-Year Est. Return
41.24%
This Quarter
Est. Return
-0.69%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$67.5B
AUM Growth
+$10.9B
(+19%)
Cap. Flow
+$12.7B
Cap. Flow
% of AUM
18.75%
Top 10 Holdings %
Top 10 Hldgs %
49.27%
Holding
2,060
New
26
Increased
289
Reduced
1,527
Closed
195
Avg Time Held
26.2
quarters
Top 10 Avg Time Held
23.4
quarters
Top 20 Avg Time Held
21.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares GENIUS Money Market ETF
IQMM
|
+$19.7B |
| 2 |
Walmart Inc
WMT
|
+$729M |
| 3 |
Kimberly-Clark
KMB
|
+$33.1M |
| 4 |
Erie Indemnity
ERIE
|
+$26.7M |
| 5 |
Becton Dickinson
BDX
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$799M |
| 2 |
Apple
AAPL
|
+$563M |
| 3 |
Microsoft
MSFT
|
+$445M |
| 4 |
Amazon
AMZN
|
+$321M |
| 5 |
Broadcom
AVGO
|
+$274M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.2% |
| 2 | Technology | 23.92% |
| 3 | Consumer Staples | 7.59% |
| 4 | Consumer Discretionary | 6.94% |
| 5 | Communication Services | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1826
Coty
COTY
$2.58B
| $29.8K | ﹤0.01% |
14,825
+92
| +0.6% | +$247 |
2016 Q4
37 quarters
|
|
1827
Ribbon Communications
RBBN
$283M
| $28.8K | ﹤0.01% |
13,597
-3,546
| -21% | -$8.49K |
2023 Q2
11 quarters
|
|
1828
Alector
ALEC
$230M
| $28.4K | ﹤0.01% |
13,188
-1,484
| -10% | -$2.98K |
2019 Q4
25 quarters
|
|
1829
Codexis
CDXS
$147M
| $27.7K | ﹤0.01% |
16,976
-3,238
| -16% | -$4.62K |
2024 Q3
6 quarters
|
|
1830
Conduent
CNDT
$235M
| $26.1K | ﹤0.01% |
20,423
-6,125
| -23% | -$9.34K |
2019 Q3
26 quarters
|
|
1831
Inhibikase Therapeutics
IKT
$247M
| $26.1K | ﹤0.01% |
15,537
+4,491
| +41% | +$7.97K |
2025 Q2
3 quarters
|
|
1832
Quantum-Si Incorporated
QSI
$302M
| $25.7K | ﹤0.01% |
33,239
-4,102
| -11% | -$4.25K |
2021 Q4
17 quarters
|
|
1833
Accendra Health
ACH
$30M
| $24.9K | ﹤0.01% |
10,931
-2,850
| -21% | -$6.56K |
2020 Q3
22 quarters
|
|
1834
Protalix BioTherapeutics
PLX
$225M
| $23K | ﹤0.01% |
10,589
-2,548
| -19% | -$6.32K |
2025 Q2
3 quarters
|
|
1835
Nano X Imaging
NNOX
$41.1M
| $22.9K | ﹤0.01% |
10,109
-1,633
| -14% | -$4.3K |
2024 Q3
6 quarters
|
|
1836
Xerox
XRX
$356M
| $22K | ﹤0.01% |
17,075
-4,446
| -21% | -$8.79K |
2013 Q2
51 quarters
|
|
1837
loanDepot
LDI
$199M
| $20.7K | ﹤0.01% |
14,560
-1,751
| -11% | -$3.6K |
2025 Q2
3 quarters
|
|
1838
Humacyte
HUMA
$110M
| $19.5K | ﹤0.01% |
32,125
-4,498
| -12% | -$4.68K |
2021 Q4
17 quarters
|
|
1839
Fate Therapeutics
FATE
$255M
| $18.9K | ﹤0.01% |
15,764
-4,108
| -21% | -$5K |
2018 Q4
29 quarters
|
|
1840
DELISTED
Open Lending Corp
LPRO
| $18.3K | ﹤0.01% |
14,662
-3,819
| -21% | -$6.04K |
2021 Q2
19 quarters
|
|
1841
Heron Therapeutics
HRTX
$78.3M
| $17.8K | ﹤0.01% |
22,275
-5,800
| -21% | -$6.72K |
2020 Q2
23 quarters
|
|
1842
Douglas Elliman
DOUG
$137M
| $17.4K | ﹤0.01% |
10,631
-2,745
| -21% | -$6.36K |
2025 Q2
3 quarters
|
|
1843
Invivyd
IVVD
$198M
| $16.1K | ﹤0.01% |
12,396
+156
| +1% | +$287 |
2025 Q4
1 quarter
|
|
1844
JELD-WEN Holding
JELD
$111M
| $15.3K | ﹤0.01% |
12,326
-3,188
| -21% | -$6.97K |
2023 Q2
11 quarters
|
|
1845
Lucid Diagnostics
LUCD
$116M
| $15K | ﹤0.01% |
13,068
-3,403
| -21% | -$4.33K |
2025 Q2
3 quarters
|
|
1846
New Fortress Energy
NFE
$23.8M
| $15K | ﹤0.01% |
509
-133
| -21% | -$7.78K |
2025 Q2
3 quarters
|
|
1847
SkinHealth Systems
SKIN
$68.3M
| $14.9K | ﹤0.01% |
16,775
-4,118
| -20% | -$5.05K |
2021 Q2
19 quarters
|
|
1848
Patriot National Bancorp
PNBK
$112M
| $14.6K | ﹤0.01% |
11,336
-1,188
| -9% | -$1.71K |
2025 Q4
1 quarter
|
|
1849
SKYX Platforms
SKYX
$149M
| $14.6K | ﹤0.01% |
13,039
-47
| -0.4% | -$98 |
2025 Q2
3 quarters
|
|
1850
Kaltura
KLTR
$212M
| $14K | ﹤0.01% |
11,450
-5,045
| -31% | -$7.18K |
2023 Q2
11 quarters
|
|
Similar funds
ProShare Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, ProShare Advisors held 2,060 positions worth $67.5B, up 19% from $56.7B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
ProShare Advisors deployed $12.7B of net new capital in Q1 2026, opening 26 new positions and adding to 289 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 0.01% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was NVIDIA, an estimated $799M trimmed.
- ProShare Advisors's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 197,028,347 shares worth $19.7B.
- ProShare Advisors added most to Walmart Inc in Q1 2026, an estimated $729M increase.
- ProShare Advisors's biggest Q1 2026 reduction was NVIDIA, cutting an estimated $799M.
- ProShare Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $85.7M.
- ProShare Advisors's ten largest holdings make up 49% of its $67.5B portfolio in Q1 2026.
- ProShare Advisors opened 26 new positions and closed 195 in Q1 2026.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $67.5B.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.